Target-directed cancer: protein-ligand interactions
Drug Target Review
NOVEMBER 1, 2023
We need to build the assays that we need for compound screening. In 2007 Dr van Montfort joined the Institute of Cancer Research (London, UK), where he holds a joint position between the Centre for Cancer Drug Discovery (CCDD) and the Division of Structural Biology.
Let's personalize your content